GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 328 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $240,000 | +15.4% | 1,108 | -8.0% | 0.00% | 0.0% |
Q2 2019 | $208,000 | -13.7% | 1,205 | -49.3% | 0.00% | -50.0% |
Q3 2017 | $241,000 | -1.2% | 2,376 | -2.2% | 0.00% | 0.0% |
Q2 2017 | $244,000 | -17.6% | 2,429 | -0.8% | 0.00% | -33.3% |
Q1 2017 | $296,000 | +25.4% | 2,448 | +15.9% | 0.00% | +50.0% |
Q4 2016 | $236,000 | -4.1% | 2,112 | +13.9% | 0.00% | 0.0% |
Q3 2016 | $246,000 | – | 1,855 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |